| 1 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
|
| 2 |
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953.
|
| 3 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 4 |
Wu SG, Chang TH, Liu YN, et al. MicroRNA in Lung Cancer Metastasis[J]. Cancers (Basel), 2019, 11(2): 265.
|
| 5 |
Vaibhav C, Akshay P, Dragana K, et al. Opposing Roles of the Fork-head box genes FoxM1 and FoxA2 in Liver Cancer[J]. Mol Cancer Res, 2019, 17(5): 1063-1074.
|
| 6 |
李佩琴，杨少芬，翁雅倩，等. 食管鳞状细胞癌中FOXM1基因的表达及临床意义[J]. 临床与实验病理学杂志，2018, 34(6): 591-594, 600.
|
| 7 |
王 建. FoxM1在前列腺癌中的表达及其临床意义[J]. 实用癌症杂志，2013, 28(2): 125-126，129.
|
| 8 |
Wang J. Expression and Clinical Significance of FoxM1 in Prostate Cancer[J]. J Cancer, 2013, 28(2): 125-126，129.
|
| 9 |
Liu B, Su F, Lin R, et al. Overexpression of forkhead box M1 is associated poor survival in patients with nonsmall cell lung cancer[J]. J Cancer Res Ther, 2018, 14(Supplement): S1121-S1123.
|
| 10 |
Su LJ, Chang CW, Wu YC, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme[J]. BMC Genomics, 2007, 8: 140.
|
| 11 |
Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung[J]. Proc Natl Acad Sci U S A, 2001, 98(24): 13784-13789.
|
| 12 |
Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma[J]. Nat Med, 2002, 8(8): 816-824.
|
| 13 |
Stearman RS, Dwyer-Nield L, Zerbe L, et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model[J]. Am J Pathol, 2005, 167(6): 1763-1775.
|
| 14 |
Hou J, Aerts J, den Hamer B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction[J]. PLoS One, 2010, 5(4): e10312.
|
| 15 |
Landi MT, Dracheva T, Rotunno M, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival[J]. PLoS One, 2008, 3(2): e1651.
|
| 16 |
Selamat SA, Chung BS, Girard L, et al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression[J]. Genome Res, 2012, 22(7): 1197-1211.
|
| 17 |
Okayama H, Kohno T, Ishii Y, et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas[J]. Cancer Res, 2012, 72(1): 100-111.
|
| 18 |
Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles[J]. Adv Cancer Res, 2013, 118: 97-398.
|
| 19 |
Gartel AL. FOXM1 in Cancer: Interactions and Vulnerabilities[J]. Cancer Res, 2017, 77(12): 3135-3139.
|
| 20 |
Zhang Y, Qiao WB, Shan L. Expression and functional characterization of FOXM1 in non-small cell lung cancer[J]. Onco Targets Ther, 2018, 11: 3385-3393.
|
| 21 |
Hou XW, Sun X, Yu Y, et al. miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1[J]. Neoplasma, 2017, 64(4): 526-534.
|
| 22 |
Carter JB, Connor B, Linda C, et al. Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer[J]. Cancers (Basel), 2019, 11(2): 251.
|
| 23 |
Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers[J]. Nat Med, 2015, 21(8): 938-945.
|